Established in 2005 as a partnership between the Institute of Cancer Medicine at the University of Oxford and 12 of India's leading pharmaceutical companies, our company is dedicated to developing and commercializing innovative cancer therapies. Our mission is to improve patient outcomes and quality...See more
Headquarters:
United Kingdom of Great Britain and Northern Ireland
Company Type:
SME
Company size:
Employees
Address:
ROOSEVELT DRIVE; HEADINGTON, OX3 7LF, GB
LOW
spending power
